Pacira BioSciences, Inc. (PCRX)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$25.39
-0.63%
Mkt Cap $1.09B
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (12 analysts)
$27.00
Range $27.00 – $27.00
Implied Upside
+6.3%
Consensus $27.00 vs current $25.39